CSPC Innovation Pharmaceutical Co Ltd Class A Cash Flow Conversion Efficiency

Latest as of December 2025: -0.009x

CSPC Innovation Pharmaceutical Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a cash flow conversion efficiency ratio of -0.009x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.98 Million ≈ $-3.80 Million USD) by net assets (CN¥2.80 Billion ≈ $409.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)

Cash flow conversion efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of CSPC Innovation Pharmaceutical Co Ltd Cl for real-time trading data and today's change.

CSPC Innovation Pharmaceutical Co Ltd Class A Cash Flow Conversion Ratio Explained

CSPC Innovation Pharmaceutical Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CSPC Innovation Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CSPC Innovation Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Also see CSPC Innovation Pharmaceutical Co Ltd Cl stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
MERUS N.V. EO -09
F:2GH
N/A
Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság
F:MGYB
0.097x
Madison Square Garden Sports Corp
NYSE:MSGS
-0.200x
OR Royalties Inc.
TO:OR
0.056x
Indian Overseas Bank
NSE:IOB
-0.682x
PrairieSky Royalty Ltd
TO:PSK
0.048x
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
-0.148x
China Aerospace Times Electronics Co Ltd
SHG:600879
0.130x

Annual Cash Flow Conversion Efficiency for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. Review free cash flow generation of CSPC Innovation Pharmaceutical Co Ltd Cl to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.80 Billion
≈ $409.04 Million
CN¥-195.69 Million
≈ $-28.64 Million
-0.070x +74.52%
2024-12-31 CN¥4.50 Billion
≈ $657.90 Million
CN¥-1.24 Billion
≈ $-180.73 Million
-0.275x -262.45%
2023-12-31 CN¥5.48 Billion
≈ $802.37 Million
CN¥927.24 Million
≈ $135.68 Million
0.169x +4.10%
2022-12-31 CN¥3.94 Billion
≈ $577.16 Million
CN¥640.72 Million
≈ $93.76 Million
0.162x +83.40%
2021-12-31 CN¥3.30 Billion
≈ $482.55 Million
CN¥292.09 Million
≈ $42.74 Million
0.089x -31.82%
2020-12-31 CN¥2.69 Billion
≈ $393.18 Million
CN¥349.07 Million
≈ $51.08 Million
0.130x -0.51%
2019-12-31 CN¥2.42 Billion
≈ $353.44 Million
CN¥315.38 Million
≈ $46.15 Million
0.131x -18.30%
2018-12-31 CN¥999.35 Million
≈ $146.24 Million
CN¥159.73 Million
≈ $23.37 Million
0.160x +9327.66%
2017-12-31 CN¥766.93 Million
≈ $112.23 Million
CN¥1.30 Million
≈ $190.26K
0.002x -99.29%
2016-12-31 CN¥572.02 Million
≈ $83.70 Million
CN¥137.27 Million
≈ $20.09 Million
0.240x +34.25%
2015-12-31 CN¥626.83 Million
≈ $91.72 Million
CN¥112.05 Million
≈ $16.40 Million
0.179x +2.85%
2014-12-31 CN¥537.16 Million
≈ $78.60 Million
CN¥93.36 Million
≈ $13.66 Million
0.174x --

About CSPC Innovation Pharmaceutical Co Ltd Class A

SHE:300765 China Packaged Foods
Market Cap
$6.11 Billion
CN¥41.76 Billion CNY
Market Cap Rank
#3033 Global
#340 in China
Share Price
CN¥29.73
Change (1 day)
-6.83%
52-Week Range
CN¥23.23 - CN¥51.78
All Time High
CN¥189977.21
About

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more